Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Appella

Showing results (341-350 of 387) with videos related to

Pageof 39
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995
Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytesP F Robbins, M el-Gamil, Y F Li, et al.
Science (New York, N.Y.)|September 11, 1998
Activation of the ATM kinase by ionizing radiation and phosphorylation of p53C E Canman, D S Lim, K A Cimprich, et al.
Cancer Research|October 23, 1997
Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cellsF Salazar-Onfray, T Nakazawa, V Chhajlani, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 1994
Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrestD Lin, M Fiscella, P M O'Connor, et al.
Science (New York, N.Y.)|December 11, 1992
Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutantA Sette, S Ceman, R T Kubo, et al.
Human Immunology|April 1, 1996
Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulinA Setini, A Beretta, C De Santis, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid proteinK Sakaguchi, N Zambrano, E T Baldwin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformationsY Chen, J Sidney, S Southwood, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapyL Rivoltini, D J Loftus, K Barracchini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1995
Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1L Rivoltini, Y Kawakami, K Sakaguchi, et al.
Pageof 39

Showing results (341-350 of 387) with videos related to

Sort By:
Pageof 39
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995
Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytesP F Robbins, M el-Gamil, Y F Li, et al.
Science (New York, N.Y.)|September 11, 1998
Activation of the ATM kinase by ionizing radiation and phosphorylation of p53C E Canman, D S Lim, K A Cimprich, et al.
Cancer Research|October 23, 1997
Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cellsF Salazar-Onfray, T Nakazawa, V Chhajlani, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 1994
Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrestD Lin, M Fiscella, P M O'Connor, et al.
Science (New York, N.Y.)|December 11, 1992
Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutantA Sette, S Ceman, R T Kubo, et al.
Human Immunology|April 1, 1996
Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulinA Setini, A Beretta, C De Santis, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid proteinK Sakaguchi, N Zambrano, E T Baldwin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformationsY Chen, J Sidney, S Southwood, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapyL Rivoltini, D J Loftus, K Barracchini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1995
Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1L Rivoltini, Y Kawakami, K Sakaguchi, et al.
Pageof 39